Related Experiment Video

Updated: Oct 3, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis

S J Kim1, Y H Im, S D Markowitz

  • 1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, MD 20892-5055, USA. kims@dce41.nci.nih.gov

Cytokine & Growth Factor Reviews
|March 10, 2000
PubMed

Insights

Transforming growth factor-beta (TGF-β) signaling is crucial for preventing cancer. Loss of TGF-β type II receptor expression, often via transcriptional repression, is a key mechanism in carcinogenesis, offering therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Transforming growth factor-beta (TGF-β) signaling pathways are critical in cellular processes and disease.
  • Dysregulation of TGF-β receptors, specifically the TGF-β type I and type II receptors, is implicated in numerous human pathologies, notably cancer.
  • The TGF-β receptor complex and its downstream effectors, including Smad proteins, function as a tumor suppressor pathway.

Purpose of the Study:

  • To review mechanisms of TGF-β type II receptor inactivation in human pathologies.
  • To differentiate between mutational inactivation and loss of expression of the TGF-β type II receptor.
  • To identify novel therapeutic targets for diseases associated with TGF-β signaling defects.

Main Methods:

  • Review of existing literature on TGF-β receptor signaling and inactivation.
  • Analysis of studies investigating microsatellite instability and TGF-β type II receptor mutations.
  • Examination of research on transcriptional repression mechanisms affecting TGF-β type II receptor expression.

Main Results:

  • Microsatellite instability can lead to mutational inactivation of the TGF-β type II receptor.
  • Transcriptional repression is identified as the predominant mechanism for loss of TGF-β type II receptor expression.
  • These findings highlight distinct pathways leading to the loss of a critical tumor suppressor function.

Conclusions:

  • Understanding the mechanisms of TGF-β type II receptor inactivation is vital for cancer research.
  • Transcriptional repression represents a significant, druggable target for therapeutic intervention in cancers with TGF-β pathway defects.
  • Targeting TGF-β signaling offers a promising avenue for novel cancer therapies.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...